Healthcare & Life Sciences
Tundra Targeted Therapeutics
About
Develops bispecific antibody technology to harness the immune system by directing T cells to attack bloodborne cancers such as leukemia and lymphoma, aiming to improve efficacy and reduce side effects compared to other immunotherapies.
Explore Tundra Targeted Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.